Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 432

1.

Rat hepatocyte engraftment in severe combined immunodeficient x beige mice using mouse-specific anti-fas antibody.

Wilson JH, Paturzo FX, Johnson LK, Carreiro MP, Hixson DC, Mennone A, Boyer JL, Pober JS, Harding MJ.

Xenotransplantation. 2006 Jan;13(1):53-62.

PMID:
16497212
2.

Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.

Jiang L, Li JG, Lan L, Wang YM, Mao Q, You JP.

Transplant Proc. 2010 Nov;42(9):3773-8. doi: 10.1016/j.transproceed.2010.08.064.

PMID:
21094855
3.

Improved xenogenic hepatocyte implantation into nude mouse liver parenchyma with acute liver failure when followed by repeated anti-Fas antibody (Jo2) treatment.

Vidal I, Blanchard N, Alexandre E, Gandillet A, Chenard-Neu MP, Staedtler F, Schumacher M, Bachellier P, Jaeck D, Firat H, Heyd B, Richert L.

Cell Transplant. 2008;17(5):507-24.

PMID:
18714670
4.

Selective repopulation of mice liver after Fas-resistant hepatocyte transplantation.

Fujino M, Li XK, Kitazawa Y, Funeshima N, Guo L, Okuyama T, Amano T, Amemiya H, Suzuki S.

Cell Transplant. 2001;10(4-5):353-61.

PMID:
11549054
6.

Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.

Matsuki Y, Li L, Hsu HC, Yang PA, Zheng R, Edwards CK 3rd, Chaudry IH, Zhang HG, Mountz JD.

Cell Death Differ. 2002 Jun;9(6):626-35.

7.

In vivo analysis of Fas antigen-mediated apoptosis: effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver.

Nishimura Y, Hirabayashi Y, Matsuzaki Y, Musette P, Ishii A, Nakauchi H, Inoue T, Yonehara S.

Int Immunol. 1997 Feb;9(2):307-16.

PMID:
9040012
8.

Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes.

Mignon A, Guidotti JE, Mitchell C, Fabre M, Wernet A, De La Coste A, Soubrane O, Gilgenkrantz H, Kahn A.

Nat Med. 1998 Oct;4(10):1185-8.

PMID:
9771754
9.

Increased survival despite failure of transplanted human hepatocyte implantation into liver parenchyma of nude mice with repeated lethal Jo2-induced liver deficiency.

Vidal I, Blanchard N, Chenard-Neu MP, Bachellier P, Heyd B, Staedtler F, Schumacher M, Alexandre E, Richert L.

Cell Transplant. 2014;23(12):1557-72. doi: 10.3727/096368913X667501. Epub 2013 Apr 29.

PMID:
23636101
10.

Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.

Douglas DN, Kawahara T, Sis B, Bond D, Fischer KP, Tyrrell DL, Lewis JT, Kneteman NM.

PLoS One. 2010 Feb 18;5(2):e9209. doi: 10.1371/journal.pone.0009209.

11.

Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model.

Nonome K, Li XK, Takahara T, Kitazawa Y, Funeshima N, Yata Y, Xue F, Kanayama M, Shinno E, Kuwae C, Saito S, Watanabe A, Sugiyama T.

Am J Physiol Gastrointest Liver Physiol. 2005 Dec;289(6):G1091-9. Epub 2005 Jul 28.

12.

Transforming growth factor-alpha accelerates hepatocyte repopulation after hepatocyte transplantation.

Kosone T, Takagi H, Horiguchi N, Kakizaki S, Sato K, Watanabe Y, Mori M.

J Gastroenterol Hepatol. 2008 Feb;23(2):260-6. Epub 2007 Aug 6.

PMID:
17683499
13.
14.

Fas siRNA reduces apoptotic cell death of allogeneic-transplanted hepatocytes in mouse spleen.

Wang J, Li W, Min J, Ou Q, Chen J.

Transplant Proc. 2003 Jun;35(4):1594-5.

PMID:
12826229
15.

Liver repopulation by Bcl-x(L) transgenic hepatocytes.

Mitchell C, Mallet VO, Guidotti JE, Goulenok C, Kahn A, Gilgenkrantz H.

Am J Pathol. 2002 Jan;160(1):31-5.

16.

Hepatic hyperplasia associated with discordant xenogeneic parenchymal-nonparenchymal interactions in human hepatocyte-repopulated mice.

Utoh R, Tateno C, Kataoka M, Tachibana A, Masumoto N, Yamasaki C, Shimada T, Itamoto T, Asahara T, Yoshizato K.

Am J Pathol. 2010 Aug;177(2):654-65. doi: 10.2353/ajpath.2010.090430. Epub 2010 Jun 3.

17.

Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.

Mai G, Nguyen TH, Morel P, Mei J, Andres A, Bosco D, Baertschiger R, Toso C, Berney T, Majno P, Mentha G, Trono D, Buhler LH.

Xenotransplantation. 2005 Nov;12(6):457-64. Erratum in: Xenotransplantation. 2006 Jan;13(1):89. Huy, Nguyen Tuan [corrected to Nguyen, Tuan Huy].

PMID:
16202069
18.

Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.

Matsuno H, Yudoh K, Nakazawa F, Sawai T, Uzuki M, Nishioka K, Yonehara S, Nakayama J, Ohtsuki M, Kimura T.

J Rheumatol. 2002 Aug;29(8):1609-14.

PMID:
12180717
19.

Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation.

Cazanave S, Vadrot N, Tinel M, Berson A, Lettéron P, Larosche I, Descatoire V, Feldmann G, Robin MA, Pessayre D.

Toxicol Appl Pharmacol. 2008 Sep 15;231(3):336-43. doi: 10.1016/j.taap.2008.05.010. Epub 2008 May 20.

PMID:
18572215
20.

Anti-CD95-induced lethality requires radioresistant Fcgamma RII+ cells. A novel mechanism for fulminant hepatic failure.

Jodo S, Kung JT, Xiao S, Chan DV, Kobayashi S, Tateno M, Lafyatis R, Ju ST.

J Biol Chem. 2003 Feb 28;278(9):7553-7. Epub 2002 Dec 10.

Supplemental Content

Support Center